fbpx Ilaria Capua won the 2014 Excellence Award | Page 20 | Science in the net

Ilaria Capua won the 2014 Excellence Award

Read time: 2 mins

Ilaria Capua will receive the 2014 Excellence Award for Clinical Microbiology and Infectious Diseases, conferred by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).

This prestigious European institution decided to bestow such an Excellence Award to the Italian scientist for her intense scientific activity but, most of all, for the key role she played within international committees by launching global initiative and challenging consolidated mechanisms in favour of new paradigms, to the benefit of public health.

This is the first time ever that a woman receives the ESCMID's Excellence Award, which will be given to Ilaria Capua on May 12th in Barcelona and will be forerun by a Lectio Magistralis entitled "Close Encounters of the Third Kind - viruses and globalisation".

"This award represents a great satisfaction for me. ESCMID is the largest society for microbiologists and experts in infectious diseases in Europe and they decided to confer me such a prize for my scientific contribute to the discipline and my struggle to bring innovative policies in public health," explained the virologist and researcher, currently member of the Italian parliament and vicepresident of the board for culture of the Italian Chamber of Deputies. "I would like to dedicate it to all Italian women working in research, for the International Women's Day, in order to witness that an Italian woman may also be the first European woman to win such an eminent award."

Autori: 
Sezioni: 
Award

prossimo articolo

We cannot archive Covid-19 yet

Coexistence with Covid-19 cannot yet be said to be stable, especially due to the great variability of SARS-CoV-2. For this reason, as the number of cases in Italy is increasing, it is necessary to limit the impact of infections by acting on two fronts, which are not alternatives to each other: reduce the share of people who have become partially susceptible and limit the likelihood of the emergence of new variants.

Image credits: Prasesh Shiwakoti (Lomash)/Unsplash

Several attempts have been made to archive Covid-19, trying to leave behind an experience worthy of the worst dystopian novel (about 770 million officially registered cases worldwide and an estimated 18 million deaths), but it seems that the anticipated "coexistence" with the family of viruses has not yet stabilized, and it will take several years to get there.